| 引用本文: | 丁海樱,辛文秀,童莹慧,方罗,李国辉.赋能肿瘤药师服务转型，助推肿瘤药学学科发展[J].中国现代应用药学,2023,40(12):1585-1587. |
| DING Haiying,XIN Wenxiu,TONG Yinghui,FANG Luo,LI Guohui.Accelerate the Transformation of Oncology Pharmacists’ Services and Promote the Development of Oncology Pharmacy[J].Chin J Mod Appl Pharm(中国现代应用药学),2023,40(12):1585-1587. |
|
| 摘要: |
| 药师是抗肿瘤治疗多学科团队的重要成员，随着药师服务转型，肿瘤药学服务的内容不断延伸，抗肿瘤药物临床综合评价、超说明书用药管理等拓展性服务是目前肿瘤药学的重要发展趋势。本期推出“肿瘤药学管理与服务”专栏，从“抗肿瘤药物前沿进展”及“抗肿瘤药物临床综合评价”两部分深入探讨，旨在为肿瘤药学管理与服务模式的探索提供新思路，从而进一步加快肿瘤药学服务转型，助推肿瘤药学学科高质量发展。 |
| 关键词: 肿瘤药师 药学服务 抗肿瘤药物综合评价 |
| DOI：10.13748/j.cnki.issn1007-7693.20231567 |
| 分类号:R95 |
| 基金项目: |
|
| Accelerate the Transformation of Oncology Pharmacists’ Services and Promote the Development of Oncology Pharmacy |
|
DING Haiying1, XIN Wenxiu1, TONG Yinghui1, FANG Luo1, LI Guohui2
|
|
1.Zhejiang Cancer Hospital, Hangzhou Institute of Medicine(HIM), Chinese Academy of Sciences, Hangzhou 310022, China;2.National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
|
| Abstract: |
| Pharmacists are important members of the multidisciplinary team of anti-tumor therapy. With the transformation of pharmacists, the content of pharmaceutical care provided by oncology pharmacists continues to extend. Expanded services such as clinical comprehensive evaluation of anti-tumor drugs and management of off-label drug use are an important development trend of oncology pharmacy. The column named “Oncology Pharmacy Management and Services” is introduced, which discussed in depth from the two parts of “frontier progress of anti-tumor drugs” and “comprehensive clinical evaluation of anti-tumor drugs”, aiming to provide new ideas for the exploration of oncology pharmaceutical services, so as to further accelerate the transformation of oncology pharmaceutical care and promote the high-quality development of oncology pharmacy. |
| Key words: oncology pharmacist pharmaceutical service clinical comprehensive evaluation of anti-tumor drugs |
